Oxford Biomedica appointed Peter Soelkner, a pharmaceutical services executive, as non-executive director as part of its transition to being a viral vector contract development and manufacturing organisation (CDMO). Mr Soelkner is currently managing director of Vetter Pharma, an aseptic filling and packaging CDMO, and previously held senior positions at Sartorius, a pharmaceutical and laboratory equipment supplier. Mr Soelkner has an MBA from Columbia Business School, New York, US, and a masters in chemical engineering from TU Dortmund University, Germany.
Oxford Biomedica announced the appointment on 11 March 2024.
Copyright 2024 Evernow Publishing Ltd